New York: A new class of antigens have been identified that may be a contributing factor to type 1 diabetes. Type-1 diabetes is the auto-immune form of diabetes, in which insulin-producing beta cells in the pancreas are destroyed by the body's own immune cells, a study finds.
"Our lab studies the type of T cell known as a CD4 T cell," said Kathryn Haskins from the University of Colorado School of Medicine in the US.
"We have focused on autoreactive CD4 T cells using a mouse model of autoimmune diabetes. We have been especially interested in identifying the antigens that activate these T cells," Ms Haskins added in the paper published in journal Science.
Normally, a CD4 T cell is supposed to respond to "foreign" antigens. But in autoimmune disease the T cells respond to antigens that are generated in the body. Such proteins and peptides are called autoantigens.
When an autoreactive T cell sees its antigen, it becomes activated and can initiate disease. By identifying those antigens, scientists may be able to use that information to detect autoreactive T cells early in disease, or better yet, in at-risk individuals.
If they are able to use the antigens to turn off destructive T cells, they may be able to prevent the disease, the study finds.
Researchers conducted experiments to analyze the fractions of beta cells that contain antigen for autoreactive CD4 T cells in order to identify autoantigens in type 1 diabetes.
They discovered a new class of antigens that consist of insulin fragments fused to peptides of other proteins present in beta cells. That fusion leads to generation of hybrid insulin peptides that are not encoded in an individual's genome.
If peptides in the body are modified from their original form, they essentially become "foreign" to the immune system and this may explain why they become targets for the autoreactive T cells.
The discovery of hybrid peptides as targets of the immune system provides a plausible explanation of how the immune system is tricked into destroying the body's own beta cells. The discovery may also lead to a better understanding of other autoimmune diseases.
"Our lab studies the type of T cell known as a CD4 T cell," said Kathryn Haskins from the University of Colorado School of Medicine in the US.
"We have focused on autoreactive CD4 T cells using a mouse model of autoimmune diabetes. We have been especially interested in identifying the antigens that activate these T cells," Ms Haskins added in the paper published in journal Science.
When an autoreactive T cell sees its antigen, it becomes activated and can initiate disease. By identifying those antigens, scientists may be able to use that information to detect autoreactive T cells early in disease, or better yet, in at-risk individuals.
Advertisement
Researchers conducted experiments to analyze the fractions of beta cells that contain antigen for autoreactive CD4 T cells in order to identify autoantigens in type 1 diabetes.
Advertisement
If peptides in the body are modified from their original form, they essentially become "foreign" to the immune system and this may explain why they become targets for the autoreactive T cells.
Advertisement
COMMENTS
Advertisement
Universal Coronavirus Vaccine? New Jab Targets Even Unknown Threats XDefiant Closed Beta Impressions: Ubisoft’s Crossover Shooter Is a Lukewarm Experience 63 Per Cent In Delhi Didn't Go For Test Despite Covid-Like Symptoms: Report How Extreme Weather Is Leading To Rise In Child Marriages In Pakistan 3 Days After Big Order On Deposits With SBI And PNB, Karnataka Hits Pause Monkeypox Cases Rising: How Worried Should You Be - 10 Points Man Scales Wall, Jumps Inside Parliament Annexe Premises, Arrested: Report "Too Many Dead": Gaza Undertakers Stacking "Graves On Top Of Graves" Musk's X Ordered To Pay Rs 5 Crore To Former Employee Over Unfair Dismissal Track Latest News Live on NDTV.com and get news updates from India and around the world.